Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.

AIDS (London, England) - 11 Jul 2008

Prendergast Andrew, Mphatswe Wendy, Tudor-Williams Gareth, Rakgotho Mpho, Pillay Visva, Thobakgale Christina, McCarthy Noel, Morris Lynn, Walker Bruce D, Goulder Philip

Abstract excerpt

OBJECTIVES: Infants infected with HIV-1 perinatally despite single-dose nevirapine progress rapidly. Data on treatment outcome in sub-Saharan African infants exposed to single-dose nevirapine are urgently required. This feasibility study addresses efficacy of infant antiretroviral therapy in this setting. METHODS: HIV-infected infants in Durban, South Africa, received randomized immediate or deferred (when CD4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Infectious Disease Transmission, Vertical

Share to Nevirapine

Share to Patient Compliance

Share to Pregnancy Complications, Infectious

Share to Socioeconomic Factors

Source

Identifiers

PMID: 18580613
DOI: 10.1097/QAD.0b013e32830437df

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.PMID 18580613Read ↗

HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine.Semantic proximity Read ↗

Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.Semantic proximity Read ↗

A trial of three antiretroviral regimens in HIV-1-infected children.Semantic proximity Read ↗

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.Semantic proximity Read ↗

Early Treatment Regimens Achieve Sustained Virologic Remission in Infant Macaques Infected with SIV at BirthSemantic proximity Read ↗

Early multitherapy including a protease inhibitor for human immunodeficiency virus type 1-infected infants.Semantic proximity Read ↗

Efficacy of short-course AZT plus 3TC to reduce nevirapine resistance in the prevention of mother-to-child HIV transmission: a randomized clinical trial.Semantic proximity Read ↗

Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa.Semantic proximity Read ↗

HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis.Semantic proximity Read ↗

Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile.Semantic proximity Read ↗

Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment.Semantic proximity Read ↗

The CARMA Study: Early Infant Antiretroviral Therapy—Timing Impacts on Total HIV-1 DNA Quantitation 12 Years LaterSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.